TL;DR — Glycine is a conditionally-essential amino acid and the smallest of the three glutathione building blocks. Human RCTs are small but real: 3 g before bed improved sleep quality and next-day performance, and 15 g/day lowered oxidative stressAn imbalance between reactive oxygen species (free radicals) produced by metabolism and the antioxidant systems that neutralize them. Full glossary → and systolic blood pressure in metabolic syndrome. The lifespan signal is preclinical only — an 8% glycine diet added 4–6% to mouse lifespan in the NIA ITP. Tier B. Start 3 g at night; the glutathioneYour body's most abundant internal antioxidant, made from glycine, cysteine, and glutamate. Full glossary → story is strongest paired with NAC (see GlyNAC).
What glycine does (and why it matters)
Glycine is the simplest amino acid, but it sits at three junctions that matter for aging biology: it is the third residue of the glutathione tripeptide (γ-glutamyl-cysteinyl-glycine), a major methyl-group sink feeding one-carbon metabolism, and an inhibitory neurotransmitter that lowers core body temperature to promote sleep. The body makes some glycine, but synthesis often falls short of demand — hence "conditionally essential." In aging, glycine availability appears to become a co-limiting factor for glutathione synthesis alongside cysteine, which is the rationale behind the GlyNAC combination.
Primary hallmarks targeted: Loss of proteostasis · Mitochondrial dysfunction · Deregulated nutrient sensing
Díaz-Flores et al. 2013 (PMID 24144057, Canadian Journal of Physiology and Pharmacology 91(10):855–860): a 3-month RCT gave 60 metabolic-syndrome patients 15 g/day glycine or placebo. Glycine reduced the oxidative-stress marker TBARS by ~25% versus placebo and significantly lowered systolic blood pressure in men (p = 0.043). This is a small, single-trial result — real human data, but not yet replicated at scale.
Mechanism — one amino acid, three levers
| Pathway | Mechanism | Hallmark link |
|---|---|---|
| Glutathione synthesis | Supplies the glycine residue of GSH; co-limiting with cysteine in aging | Proteostasis / Mitochondrial dysfunction |
| One-carbon metabolism | Acts as a methyl-group acceptor/donor, buffering the methylation economy | Deregulated nutrient sensing |
| CNS thermoregulation | Activates NMDA receptors in the suprachiasmatic nucleus → peripheral vasodilation and lower core temperature → faster sleep onset | Altered intercellular communication |
The sleep mechanism is preclinical. Kawai et al. 2015 (PMID 25533534, Neuropsychopharmacology 40(6):1405–1416) showed in rats that oral glycine's sleep-promoting and hypothermic effects are mediated by NMDA receptors in the suprachiasmatic nucleus — blocking those receptors or lesioning the SCN abolished the effect. This explains the human sleep findings mechanistically but is animal data.
When glycine is worth your money
Glycine earns a place in your stack when two or more apply:
- You have unsatisfactory sleep quality or sleep-onset latency and want a cheap, well-tolerated first thing to try before anything sedating
- You are building a glutathione strategy and are already taking (or adding) NAC — glycine is the second substrate
- You have metabolic-syndrome features and want a low-risk adjunct to lifestyle work
Skip or defer if your only goal is "longevity" per se — the direct lifespan evidence is preclinical, and dietary protein already supplies grams of glycine daily.
Evidence summary
| Study | Design | N | Duration | Key outcomes | Tier |
|---|---|---|---|---|---|
| Díaz-Flores 2013 (PMID 24144057) | RCT, metabolic syndrome | 60 | 3 months | ↓ TBARS ~25%, ↓ systolic BP in men | B |
| Bannai 2012 (PMID 22529837) | Crossover, sleep-restricted | 10 | Acute | ↓ fatigue/sleepiness, better vigilance next day | B |
| Kumar 2023 — GlyNAC (PMID 35975308) | RCT, older adults | 24 | 16 wk | ↑ glutathione, ↓ oxidative stress, ↑ mitochondrial function (glycine + NAC) | A (for the combination) |
| Miller 2019 — NIA ITP (PMID 30916479) | Mouse lifespan | ~1000+ | Lifelong | 8% glycine diet → +4–6% median lifespan, both sexes | C (preclinical) |
← Swipe for more columns →
Consensus: Tier B. Glycine has genuine but small human RCT evidence for two specific endpoints — sleep quality and metabolic-syndrome oxidative stress — plus a mechanistic story and a modest preclinical lifespan signal. It does not have a large, replicated human longevity trial. The strongest aging-relevant human data (Kumar 2023) is for glycine combined with NAC, not glycine alone.
Where glycine disappoints
- The human trials are tiny. The sleep data rest on ~10-person crossover work and the metabolic data on a single 60-person RCT — real, but not robust. - The lifespan signal is mouse-only and modest. An 8% glycine diet added just 4–6% to mouse median lifespan; there's no human longevity trial. - You may already get plenty. Dietary protein supplies grams of glycine daily — for a well-fed omnivore chasing "longevity," a supplement adds little on its own.
Should you start glycine?
Is sleep quality or sleep-onset latency your main target?
Try 3 g dissolved in water 30–60 min before bed for 2–4 weeks; log subjective sleep and morning alertness
node | Are you already taking NAC, or building a glutathione stack?
Add glycine as the second GSH substrate — consider the GlyNAC protocol instead of glycine alone
node | Do you have metabolic-syndrome features?
Discuss a higher divided dose (trial used 15 g/day) with a clinician as a lifestyle adjunct
Glycine is low-risk but low-yield here — prioritize better-evidenced levers
Taking clozapine, or on protein-restricted renal/hepatic diets → clinician clearance before dosing grams of an amino acid
Educational decision aid — a way to organize the evidence, not a prescription. Doses and timing shown are those used in studies; confirm anything you act on with a clinician or pharmacist.
Dosing protocol
| Parameter | Recommendation | Notes |
|---|---|---|
| Sleep dose | 3 g before bed | Matches Yamadera/Bannai human sleep work; sweet taste, dissolves in water |
| Metabolic dose | Up to 15 g/day, divided | Trial-anchored (Díaz-Flores) — larger dose, use under guidance |
| Glutathione dose | Pair with NAC | See GlyNAC for the combination protocol |
| Timing | PM for sleep; divided for metabolic | Bedtime dose leverages the hypothermia mechanism |
| Duration | 2–4 wk (sleep) to 12+ wk (metabolic) | Sleep effects are near-term; oxidative markers take months |
Week-one compliance checklist
- [ ] Choose your target: sleep (3 g PM) vs. glutathione (pair with NAC) vs. metabolic (divided, clinician-guided)
- [ ] Dissolve glycine powder in water — it is naturally sweet and easy to take
- [ ] Log baseline subjective sleep quality (1–10) and morning alertness
- [ ] If pairing with NAC, follow the GlyNAC AM protocol separately from the PM sleep dose
- [ ] Reassess sleep at 2–4 weeks; oxidative/metabolic markers at 12 weeks
Add glycine to your stack
Glycine pairs most meaningfully with NAC — toggle both to see the GlyNAC glutathione synergyWhen two compounds together produce greater effect than either alone. Full glossary → update.
Open Stack ArchitectMonitoring
| Biomarker | Target | Frequency | Action if off-target |
|---|---|---|---|
| Subjective sleep quality (1–10) | Trending up | Daily log, review at 2–4 wk | No change by 4 wk → glycine may not be your sleep lever |
| Systolic blood pressure | Stable or trending down | Baseline, 12 wk | No change → the metabolic effect was male-specific and small; don't over-rely on it |
| Glutathione (GSH) | 5.0–8.5 μmol/L | Baseline, 12 wk (if pairing with NAC) | Below range → this is the GlyNAC use-case, not glycine alone |
| hs-CRP | <1.0 mg/L | 3–6 months | Persistently high → review broader inflammation drivers |
← Swipe for more columns →
Sleep-onset latency
Prolonged
TBARS (oxidative stress)
Elevated
Systolic BP (men)
Elevated
Sleep-onset latency
Shorter (subjective + PSG in trials)
TBARS (oxidative stress)
~25% lower vs placebo (metabolic syndrome, 3 mo)
Systolic BP (men)
Modestly lower
Track your markers
Log subjective sleep nightly and oxidative/metabolic markers quarterly to see whether glycine is doing measurable work for you.
Open Labs hubSafety, red flags, and contraindications
- Generally very well tolerated — glycine is a dietary amino acid; gram doses are used routinely in trials with few adverse effects.
- Mild GI effects (soft stool, nausea) possible at higher divided doses — take with food and titrate.
- Not a sedative — it shortens sleep latency via thermoregulation, not sedation; do not treat it as a sleeping pill substitute.
Do not self-start without clearance
- Clozapine — glycine may reduce clozapine efficacy (it acts on the same NMDA-glycine site); avoid combining without psychiatric oversight.
- Renal or hepatic protein restriction — dosing grams of an amino acid can matter on a restricted-nitrogen diet; clear it with your physician.
- Pregnancy/nursing — no adequate supplementation-dose safety data; use dietary intake only.
What would change this grade. Glycine is B on small single trials. Replicated, larger RCTs for sleep or metabolic endpoints would strengthen it; its aging case largely belongs to GlyNAC and would move with that combination's evidence, not glycine alone.
Who should skip glycine
- Well-fed omnivores taking it purely "for longevity" — dietary protein already supplies grams; the isolated longevity case is preclinical. - Anyone on clozapine — glycine acts on the same NMDA-glycine site and may reduce its efficacy; psychiatric oversight required. - People on protein-restricted renal or hepatic diets — dosing grams of an amino acid needs clinician sign-off.
Synergies and antagonists
Pairs well with:
| Partner | Rationale | Guide |
|---|---|---|
| NAC | Supplies cysteine, the other co-limiting glutathione precursor — the combination is what carries the older-adult RCT evidence | NAC module |
| GlyNAC | The formal glycine + NAC combination with Tier A older-adult trial data for glutathione and mitochondrial markers | GlyNAC module |
Works against / redundant with:
| Antagonist | Conflict | What to do |
|---|---|---|
| Clozapine | Glycine occupies the same NMDA-glycine co-agonist site and may blunt the drug's antipsychotic effect | Avoid without psychiatric oversight |
| Standalone GlyNAC in the stack | Glycine is already GlyNAC's glycine leg — running both duplicates it | Don't stack separate glycine on top of GlyNAC |
| — | No other well-characterized antagonists at gram doses | Otherwise co-stacks freely |
Personal results template
My Glycine results log
| Date | Week | Dose | Sleep quality (1–10) | Morning alertness (1–10) | Systolic BP | Notes |
|---|---|---|---|---|---|---|
| YYYY-MM-DD | 0 | — | — | — | — | Baseline |
| YYYY-MM-DD | 4 | 3 g PM | — | — | — | Sleep endpoint |
| YYYY-MM-DD | 12 | — | — | — | — | Metabolic/oxidative endpoint |
← Swipe for more columns →
Response criteria (personal, not clinical): - Meaningful: Faster sleep onset or better morning alertness within 2–4 weeks, or measurably lower oxidative/metabolic markers at 12 weeks. - Plateau: No subjective or lab change → glycine is not your lever; reallocate to NAC-paired GlyNAC or other targets. - Adverse: GI intolerance → take with food and reduce dose; any interaction concern on clozapine → stop and consult.
See the glutathione combination
Glycine's clearest aging-relevant human evidence comes when it's paired with NAC — see how the two substrates work together.
GlyNAC deep-diveReferences
- PMID 24144057
- PMID 25533534
- PMID 22529837
- Kumar P et al. GlyNAC improves multiple hallmarks of aging in 16-week RCT. J Gerontol A (2023). PMID 35975308
- PMID 30916479
Links open PubMed. TNiC does not sell supplements; citations support education, not medical advice.